Physician

Mark A. Thompson, MD

According to 2025 Medicare claims, Mark Thompson, MD (NPI: 1669444030) practices radiation oncology in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Clay, MO. This provider's primary affiliated billing organization is KANSAS CITY UROLOGY CARE, P.A. (NPI: 1528024676; TIN: 481216340) and primary practice location at 64057-1824. Thompson is affiliated with the Centrus Health LLC (ACO ID: A5304), participating under the MSSP model.

Thompson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 435 traditional Medicare patients, billed 12,316 HCPCS/CPT codes, and received $2,064,506 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 387 prescription claims across 149 beneficiaries totaling $64,633 in drug costs, led by Orgovyx (Relugolix). 2015 DME data shows 23 claims. Open Payments data shows 47 records totaling $1,166. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $282,906 to $2,064,506. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $46,879 to $64,633. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.